Allmed Medical released its 2026 interim report, with attributable net profit for the first half at 194 million yuan, down 3.2% year on year. Operating revenue was 1.839 billion yuan, up 9.7% year on year. Attributable net profit excluding non-recurring items was 191 million yuan, up 2.9% year on year. Net operating cash flow was negative 40.9 million yuan, down 111.9% year on year. In the second quarter, operating revenue was 942 million yuan, up 2.7% year on year, while attributable net profit was 84.57 million yuan, down 25.4% year on year. The company flagged risks including a high share of export revenue, raw material price fluctuations, and exchange rate volatility. However, domestic revenue rose 17.99% year on year, cross-border e-commerce revenue measured in US dollars grew 67% year on year, and sales of high-margin products such as hygiene care products and advanced wound dressings increased 91.97% and 13.90% respectively.
Allmed Medical Products Co Ltd Class AH1 attributable net profit fell 3.2% YoY and Q2 profit dropped 25.4% YoY, with net operating cash flow down 111.9%.
